What is Ducommun Incorporated's earnings per share (EPS)?

Ducommun Incorporated (DCO) reported diluted earnings per share of -$2.50 for fiscal year 2025. This represents a -273.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ducommun Incorporated (DCO) Financials

DCO NYSE

Trailing 12 months to July 4, 2026

Revenue $865.1M +9.2% YoY

Net Income -$21.2M -170.3% YoY

EPS (Diluted) -$1.51 -175.5% YoY

Free Cash Flow -$24.5M -160.2% YoY

Market Cap $2.4B as of Oct 23, 2026

Price / Sales 2.7x on $865.1M revenue, trailing 12 months to July 4, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to July 4, 2026

Price / Book 3.4x on $690.4M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 4, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DCO SEC filings page.

Ducommun Incorporated (DCO) reported $865.1M in revenue over the twelve months to Jul 4, 2026, up 9.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DCO FY2025 2026-10-25

Revenue and gross margin improved, but FY2025 turned that progress into operating losses and negative cash flow as financing became more important.

Gross profit reached $221.6M and gross margin widened to 26.9%, so the spread between sales and direct costs was not the immediate constraint. Still, operating margin fell 9.7 percentage points to -4.3% while operating cash flow also turned negative, showing the deterioration extended beyond accounting profit.

Cash conversion reversed sharply: operating cash flow moved from $34.2M in FY2024 to -$33.4M in FY2025, so reported earnings did not translate into cash when profitability reversed. Free cash flow fell to -$48.6M despite capital expenditures of $15.2M, indicating the shortfall was broader than reinvestment alone.

Borrowing increased as earnings weakened: long-term debt rose from $230.7M to $300M, increasing reliance on financing. Equity fell 2.7% while the current ratio stood at 3.5x, separating near-term payment capacity from the deterioration in profitability.

Financial Health Signals

Financial Health Score 46/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ducommun Incorporated's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Ducommun Incorporated has an operating margin of -4.3%, meaning the company loses $4 on every $100 of revenue. This results in a profitability score of 32/100. This is down from 5.4% the prior year.

Growth

Ducommun Incorporated's revenue grew a modest 4.9% year-over-year to $824.8M. This slow but positive growth earns a score of 47/100.

Leverage

Ducommun Incorporated has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 62/100.

Liquidity

With a current ratio of 3.49, Ducommun Incorporated holds $3.49 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 83/100.

Cash Flow

Ducommun Incorporated's operations used $33.4M of cash, and capex of $15.2M added to the outflow, for a free cash flow shortfall of $48.6M. This results in a cash flow score of 22/100.

Returns

Ducommun Incorporated posts a -5.7% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 31/100. This is down from 3.2% the prior year.

Altman Z-Score Safe

4.24

Ducommun Incorporated scores 4.24, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $2.4B against total liabilities of $524.9M. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak

3/9

Ducommun Incorporated passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality No Cash Backing

N/A

Ducommun Incorporated reported a net loss of $37.4M while operations used $33.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

Ducommun Incorporated reported an operating loss of $35.7M against $12.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$224.5M

YoY+4.7%

QoQ+7.4%

5Y CAGR+7.0%

10Y CAGR+5.3%

Ducommun Incorporated generated $224.5M in revenue in Q3 2026. This represents an increase of 4.7% from the same quarter a year earlier. Against the prior quarter it is up 7.4%.

EBITDA

$36.9M

YoYn/m

QoQ+54.0%

5Y CAGR+12.9%

Ducommun Incorporated's EBITDA was $36.9M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 54.0%.

Net Income

$20.4M

YoYn/m

QoQ+105.7%

5Y CAGR+19.4%

10Y CAGR+18.1%

Ducommun Incorporated reported $20.4M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 105.7%.

EPS (Diluted)

$1.31

YoYn/m

QoQ+104.7%

5Y CAGR+13.7%

10Y CAGR+14.4%

Ducommun Incorporated earned $1.31 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 104.7%.

Cash & Balance Sheet

Free Cash Flow

$30.0M

YoY+87.2%

QoQ+260.9%

5Y CAGR+61.7%

10Y CAGR+26.7%

Ducommun Incorporated generated $30.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 87.2% from the same quarter a year earlier. Against the prior quarter it is up 260.9%.

Cash & Debt

$39.8M

YoY-21.8%

QoQ+1.8%

5Y CAGR+27.1%

10Y CAGR+15.8%

Ducommun Incorporated held $39.8M in cash against $272.5M in long-term debt as of Q3 2026.

Shares Outstanding

15M

YoY+1.0%

QoQ+0.1%

5Y CAGR+4.8%

10Y CAGR+3.1%

Ducommun Incorporated had 15M shares outstanding in Q3 2026. This represents an increase of 1.0% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

28.0%

YoY+0.5pp

QoQ+1.1pp

5Y change+5.1pp

10Y change+8.4pp

Ducommun Incorporated's gross margin was 28.0% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Operating Margin

12.6%

YoY+47.8pp

QoQ+5.1pp

5Y change+4.5pp

Ducommun Incorporated's operating margin was 12.6% in Q3 2026, reflecting core business profitability. This is up 47.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.1 percentage points.

Net Margin

9.1%

YoY+37.5pp

QoQ+4.3pp

5Y change+3.8pp

10Y change+6.2pp

Ducommun Incorporated's net profit margin was 9.1% in Q3 2026, showing the share of revenue converted to profit. This is up 37.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.3 percentage points.

Return on Equity

2.9%

YoY+12.3pp

QoQ+1.5pp

5Y change+0.5pp

10Y change+1.1pp

Ducommun Incorporated's quarterly ROE was 2.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 12.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.5 percentage points.

Capital Allocation

Capital Expenditures

$3.6M

YoY+71.2%

QoQ+21.9%

5Y CAGR+4.8%

10Y CAGR-0.6%

Ducommun Incorporated invested $3.6M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 71.2% from the same quarter a year earlier. Against the prior quarter it is up 21.9%.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

DCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DCO quarterly income statement

Metric	TTM	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$865.1M	$824.8M+4.9%	$786.4M+3.9%	$757.0M+6.2%	$712.5M+10.4%	$645.4M+2.6%	$628.9M-12.8%	$721.1M+14.6%	$629.3M+12.7%	$558.2M+1.4%	$550.6M-17.3%	$666.0M-10.2%	$742.0M+0.7%	$736.6M-1.4%	$747.0M+28.6%	$580.9M
Cost of Revenue	$627.7M	$603.2M+2.4%	$589.2M-0.8%	$593.8M+4.5%	$568.2M+13.0%	$503.0M+2.4%	$491.2M-13.7%	$568.9M+12.3%	$506.7M+11.4%	$455.1M+2.5%	$444.1M-21.4%	$565.2M-6.1%	$601.7M-2.0%	$614.2M+1.4%	$605.6M+27.5%	$475.0M
Gross Profit	$237.3M	$221.6M+12.3%	$197.3M+20.9%	$163.2M+13.1%	$144.3M+1.3%	$142.5M+3.4%	$137.7M-9.5%	$152.2M+24.1%	$122.6M+18.9%	$103.1M-3.2%	$106.5M+5.7%	$100.8M-28.2%	$140.3M+13.0%	$124.2M-13.8%	$144.0M+35.9%	$105.9M
SG&A Expenses	$143.2M	$147.8M-0.5%	$148.6M+24.1%	$119.7M+21.7%	$98.4M+5.1%	$93.6M+4.2%	$89.8M-6.4%	$96.0M+14.2%	$84.0M+6.2%	$79.1M+2.6%	$77.1M-7.9%	$83.8M-5.4%	$88.6M+4.4%	$84.8M-2.5%	$87.1M+1.5%	$85.8M
Operating Income	-$14.4M	-$35.7M-184.6%	$42.2M+46.0%	$28.9M-27.3%	$39.8M-18.6%	$48.9M+7.4%	$45.5M-19.1%	$56.2M+135.1%	$23.9M+53.0%	$15.6M-46.5%	$29.2Mn/m	-$75.3M-245.5%	$51.8M+31.7%	$39.3M-31.0%	$56.9Mn/m	-$34.1M
EBITDA	N/A	-$2.1M-102.7%	$75.7M+23.0%	$61.5M-13.7%	$71.2M-7.8%	$77.3M+3.9%	$74.4M-12.0%	$84.5M+71.8%	$49.2M+27.9%	$38.5M-26.1%	$52.1Mn/m	-$48.5M-160.0%	$80.8M+15.0%	$70.2M-18.7%	$86.3Mn/m	-$12.7M
Interest Expense	$13.9M	$12.7M-17.2%	$15.3M-26.3%	$20.8M+79.5%	$11.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$7.7M	-$9.9M-288.8%	$5.2M+1061.6%	$451K-90.1%	$4.5M-87.0%	$34.9M+1145.0%	$2.8M-47.1%	$5.3M+329.0%	$1.2Mn/m	-$12.5M-197.0%	$12.9Mn/m	-$31.7M-597.6%	$6.4Mn/m	-$2.0M-130.7%	$6.5Mn/m	-$4.7M
Net Income	-$21.2M	-$37.4M-272.3%	$21.7M+36.1%	$15.9M-44.7%	$28.8M-78.8%	$135.5M+364.6%	$29.2M-10.1%	$32.5M+259.3%	$9.0M-55.0%	$20.1M-20.5%	$25.3Mn/m	-$74.9M-476.9%	$19.9M+74.6%	$11.4M-35.4%	$17.6Mn/m	-$47.6M
EPS (Basic)	N/A	-$2.50-270.1%	$1.47+26.7%	$1.16-51.3%	$2.38-79.1%	$11.41+356.4%	$2.50-11.3%	$2.82+257.0%	$0.79-55.6%	$1.78-21.6%	$2.27n/m	-$6.78-472.5%	$1.82+71.7%	$1.06-36.5%	$1.67n/m	-$4.52
EPS (Diluted)	-$1.51	-$2.50-273.6%	$1.44+26.3%	$1.14-51.1%	$2.33-78.9%	$11.06+351.4%	$2.45-10.9%	$2.75+257.1%	$0.77-55.7%	$1.74-22.3%	$2.24n/m	-$6.78-478.8%	$1.79+70.5%	$1.05-36.7%	$1.66n/m	-$4.52
Diluted Shares (Avg)	N/A	15M-0.5%	15M+7.5%	14M+13.0%	12M+0.9%	12M+2.7%	12M+1.2%	12M+1.1%	12M+0.9%	12M+2.3%	11M+2.3%	11M-0.7%	11M+2.5%	11M+2.1%	11M+0.9%	11M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-K/A	Q3'2510-K/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-K/A
Revenue	$224.5M+4.7%	$209.0M+4.1%	$217.1M+10.1%	$214.4M+6.5%	$200.8M+2.4%	$192.5M+0.4%	$197.2M+2.6%	$201.4M+2.6%
Cost of Revenue	$161.6M+3.9%	$152.8M+3.4%	$157.9M+4.7%	$155.5M+4.5%	$147.8M+1.9%	$142.0M-1.8%	$150.8M+0.2%	$148.7M-1.9%
Gross Profit	$62.9M+6.7%	$56.2M+6.1%	$59.2M+27.6%	$59.0M+11.9%	$53.0M+3.7%	$50.5M+7.2%	$46.4M+11.3%	$52.7M+18.1%
SG&A Expenses	$34.6M+1.6%	$40.5M+16.9%	$34.1M+1.4%	$34.0M-3.7%	$34.6M-25.6%	$45.0M+36.2%	$33.6M+8.6%	$35.3M+9.8%
Operating Income	$28.3Mn/m	$15.7M-11.3%	$16.9M+55.4%	-$75.3M-588.2%	$17.7M+438.1%	$5.0M-60.6%	$10.9M+21.6%	$15.4M+79.2%
EBITDA	$36.9Mn/m	$24.0M-7.8%	$25.3M+32.2%	-$67.0M-379.6%	$26.0M+125.3%	$13.6M-35.4%	$19.2M+12.2%	$24.0M+40.2%
Interest Expense	$3.5M+20.3%	$4.0M+33.3%	$3.5M-3.8%	$2.9M-23.6%	$3.0M-24.3%	$3.3M-16.0%	$3.6M	$3.8M-28.7%
Income Tax	$4.4Mn/m	$1.8M-51.6%	$3.5M+429.5%	-$17.4M-893.5%	$3.7Mn/m	$310K-87.0%	$662Kn/m	$2.2M+8342.3%
Net Income	$20.4Mn/m	$9.9M-22.3%	$9.3M+41.5%	-$60.8M-746.8%	$12.8Mn/m	$1.4M-78.0%	$6.6M+28.9%	$9.4M+192.7%
EPS (Basic)	$1.35n/m	$0.66-22.4%	$0.62+40.9%	-$4.06-734.4%	$0.85n/m	$0.09-79.1%	$0.44+25.7%	$0.64+190.9%
EPS (Diluted)	$1.31n/m	$0.64-23.8%	$0.60+36.4%	-$4.06-744.4%	$0.84n/m	$0.09-79.1%	$0.44+25.7%	$0.63+186.4%
Diluted Shares (Avg)	16M+3.9%	16M+2.5%	15M+2.1%	15M-0.4%	15M+3.0%	15M+1.6%	15M	15M+1.5%

Not reported in any period shown, so not listed: R&D Expenses.

DCO Balance Sheet

DCO quarterly balance sheet

Metric	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.2B+5.3%	$1.1B+0.5%	$1.1B+9.7%	$1.0B+4.4%	$978.7M+16.9%	$837.3M+5.9%	$790.4M+22.6%	$644.7M+13.8%	$566.8M+10.0%	$515.4M-7.5%	$557.1M-25.5%	$747.6M-2.0%	$762.6M-2.2%	$780.1M-3.5%	$808.1M
Current Assets	$626.0M+10.2%	$568.1M+3.4%	$549.6M+4.2%	$527.3M+7.1%	$492.6M+20.1%	$410.3M+20.4%	$340.8M+20.0%	$284.1M+28.5%	$221.0M-2.2%	$225.9M-14.2%	$263.3M-19.9%	$328.7M-1.5%	$333.6M+1.2%	$329.6M-3.3%	$340.8M
Cash & Equivalents	$45.3M+21.9%	$37.1M-13.4%	$42.9M-7.3%	$46.2M-39.4%	$76.3M+35.2%	$56.5M+42.6%	$39.6M+285.7%	$10.3M+377.3%	$2.1M-71.1%	$7.4M+36.3%	$5.5M-88.0%	$45.6M-6.5%	$48.8M+4.9%	$46.5M+12.3%	$41.4M
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Inventory	$182.8M-7.2%	$197.0M-1.1%	$199.2M+16.3%	$171.2M+13.4%	$150.9M+16.8%	$129.2M+14.9%	$112.5M+11.2%	$101.1M-17.2%	$122.2M+1.9%	$119.9M+3.9%	$115.4M-19.2%	$142.8M+1.7%	$140.5M-5.3%	$148.3M-4.0%	$154.5M
Accounts Receivable	$124.4M+13.4%	$109.7M+4.8%	$104.7M+0.7%	$104.0M+43.9%	$72.3M+24.5%	$58.0M-13.6%	$67.1M-1.0%	$67.8M-8.4%	$74.1M-2.9%	$76.2M-1.1%	$77.1M-15.3%	$91.1M-0.9%	$91.9M-5.5%	$97.3M+1.2%	$96.2M
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$244.6M0.0%	$244.6M0.0%	$244.6M+20.3%	$203.4M-0.1%	$203.7M+19.2%	$170.8M-0.1%	$170.9M+25.6%	$136.1M+15.9%	$117.4M+42.3%	$82.6M0.0%	$82.6M-47.6%	$157.6M0.0%	$157.6M-2.7%	$161.9M-1.2%	$163.8M
Total Liabilities	$524.9M+17.7%	$446.2M-8.0%	$484.8M-2.2%	$495.5M-1.7%	$504.1M-0.8%	$508.0M+2.1%	$497.6M+28.3%	$387.9M+17.1%	$331.2M+9.2%	$303.3M-18.3%	$371.3M-24.4%	$491.0M-7.1%	$528.4M-5.2%	$557.4M-7.7%	$603.8M
Current Liabilities	$179.2M+2.1%	$175.5M-4.5%	$183.7M-7.9%	$199.4M+22.7%	$162.6M+13.8%	$142.9M-1.2%	$144.7M+14.3%	$126.5M+57.7%	$80.2M-7.0%	$86.3M+3.2%	$83.6M-24.7%	$111.1M+2.6%	$108.3M+2.3%	$105.8M-9.1%	$116.5M
Non-Current Liabilities	$345.7M+27.7%	$270.6M-10.1%	$301.1M+1.7%	$296.1M-13.3%	$341.6M-6.4%	$365.1M+3.4%	$352.9M+35.0%	$261.4M+4.2%	$250.9M+15.6%	$217.0M-24.6%	$287.7M-24.3%	$380.0M-9.6%	$420.1M-7.0%	$451.6M-7.3%	$487.3M
Long-Term Debt	$300.0M+30.1%	$230.7M-10.7%	$258.2M+6.6%	$242.2M-13.7%	$280.7M-10.5%	$313.6M+3.5%	$303.0M+31.4%	$230.7M+5.8%	$218.1M+28.3%	$170.0M-30.6%	$245.0M-15.5%	$290.0M0.0%	$290.0M-20.0%	$362.7M-7.1%	$390.3M
Total Equity	$661.5M-2.7%	$680.1M+6.9%	$636.1M+20.9%	$526.0M+10.8%	$474.6M+44.1%	$329.3M+12.5%	$292.8M+14.0%	$256.8M+9.0%	$235.6M+11.1%	$212.1M+14.2%	$185.7M-27.6%	$256.6M+9.5%	$234.3M+8.9%	$215.2M+10.0%	$195.6M
Retained Earnings	$406.3M-8.4%	$443.7M+5.1%	$422.0M+3.9%	$406.1M+7.6%	$377.3M+56.1%	$241.7M+13.7%	$212.6M+17.9%	$180.4M+11.8%	$161.4M+14.2%	$141.3M+21.8%	$116.0M-39.2%	$190.9M+11.6%	$171.0M+3.4%	$165.5M+11.0%	$149.0M

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-K/A	Q3'2510-K/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-K/A
Total Assets	$1.2B-2.1%	$1.2B+4.1%	$1.2B+5.3%	$1.3B+10.6%	$1.1B+0.6%	$1.1B-0.2%	$1.1B+0.5%	$1.1B-1.1%
Current Assets	$661.4M-3.0%	$633.9M+6.3%	$626.0M+10.2%	$681.9M+19.5%	$596.3M+4.7%	$578.1M+2.7%	$568.1M+3.4%	$570.5M+2.5%
Cash & Equivalents	$39.8M-21.8%	$39.1M+5.4%	$45.3M+21.9%	$50.9M+36.6%	$37.1M+26.2%	$30.7M-4.2%	$37.1M-13.4%	$37.3M+37.0%
Short-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Inventory	$191.7M-1.5%	$186.3M-6.2%	$182.8M-7.2%	$194.7M+4.8%	$198.6M-1.6%	$198.0M-4.9%	$197.0M-1.1%	$185.8M-13.7%
Accounts Receivable	$146.9M+32.0%	$137.0M+16.1%	$124.4M+13.4%	$111.3M+3.3%	$118.0M+10.7%	$117.8M+12.8%	$109.7M+4.8%	$107.7M+3.0%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%	$244.6M0.0%
Total Liabilities	$534.1M-11.1%	$515.5M+19.0%	$524.9M+17.7%	$601.1M+29.0%	$433.3M-9.1%	$436.3M-10.2%	$446.2M-8.0%	$465.9M-8.1%
Current Liabilities	$197.0M-41.1%	$172.6M-5.4%	$179.2M+2.1%	$334.3M+88.9%	$182.5M-1.4%	$171.7M-8.6%	$175.5M-4.5%	$177.0M-6.9%
Non-Current Liabilities	$337.1M+26.4%	$343.0M+36.7%	$345.7M+27.7%	$266.7M-7.7%	$250.9M-14.0%	$264.6M-11.2%	$270.6M-10.1%	$288.9M-8.8%
Long-Term Debt	$272.5M+26.4%	$298.8M+36.6%	$300.0M+30.1%	$215.6M-12.7%	$218.8M-13.2%	$230.7M-9.6%	$230.7M-10.7%	$246.9M-7.3%
Total Equity	$690.4M+6.3%	$669.8M-5.1%	$661.5M-2.7%	$649.2M-2.2%	$705.8M+7.7%	$692.1M+7.3%	$680.1M+6.9%	$664.1M+4.5%
Retained Earnings	$436.6M+10.0%	$416.2M-9.1%	$406.3M-8.4%	$397.0M-9.2%	$457.8M+7.0%	$445.1M+3.9%	$443.7M+5.1%	$437.1M+4.8%

DCO Cash Flow Statement

DCO quarterly cash flow statement

Metric	TTM	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$11.8M	-$33.4M-197.7%	$34.2M+10.0%	$31.1M-4.9%	$32.7Mn/m	-$565K-104.5%	$12.6M-75.3%	$51.0M+10.4%	$46.2M+30.5%	$35.4M-18.1%	$43.3M+82.7%	$23.7M-55.7%	$53.4M+16.2%	$46.0M-3.3%	$47.5Mn/m	-$3.0M
Depreciation & Amortization	N/A	$33.7M+0.7%	$33.4M+2.7%	$32.6M+3.7%	$31.4M+10.7%	$28.4M-1.6%	$28.9M+1.9%	$28.3M+11.9%	$25.3M+10.7%	$22.8M-0.1%	$22.9M-14.8%	$26.8M-7.5%	$29.0M-6.2%	$30.9M+5.1%	$29.4M+37.1%	$21.5M
Stock-Based Compensation	N/A	$28.5M+5.6%	$26.9M+79.1%	$15.0M+40.0%	$10.7M-4.2%	$11.2M+20.6%	$9.3M+29.9%	$7.2M+42.1%	$5.0M+7.8%	$4.7M+55.5%	$3.0M-14.0%	$3.5M-6.2%	$3.7M+52.8%	$2.4M+24.5%	$2.0M-17.1%	$2.4M
Capital Expenditures	$12.7M	$15.2M+7.8%	$14.1M-27.6%	$19.5M-0.8%	$19.7M+16.8%	$16.9M+34.8%	$12.5M-31.6%	$18.3M+3.8%	$17.6M-36.2%	$27.6M+62.4%	$17.0M+7.0%	$15.9M-12.2%	$18.1M+45.9%	$12.4M-21.6%	$15.8M+8.8%	$14.5M
Free Cash Flow	-$24.5M	-$48.6M-342.6%	$20.1M+73.7%	$11.5M-11.1%	$13.0Mn/m	-$17.4M-17355.4%	$101K-99.7%	$32.7M+14.4%	$28.6M+265.8%	$7.8M-70.2%	$26.3M+237.3%	$7.8M-78.0%	$35.3M+5.3%	$33.6M+5.8%	$31.7Mn/m	-$17.5M
Investing Cash Flow	-$12.5M	-$13.1Mn/m	-$13.9Mn/m	-$133.5Mn/m	-$19.2M-133.3%	$57.8Mn/m	-$5.5Mn/m	-$94.9Mn/m	-$47.9Mn/m	-$86.2M-347.0%	$34.9Mn/m	-$13.5Mn/m	-$15.5Mn/m	-$12.3Mn/m	-$15.8Mn/m	-$339.8M
Financing Cash Flow	$27.0M	$54.7Mn/m	-$26.0M-126.2%	$99.0Mn/m	-$43.5Mn/m	-$37.3M-483.2%	$9.7M-86.7%	$73.2M+646.5%	$9.8M-78.4%	$45.5Mn/m	-$76.2Mn/m	-$50.4Mn/m	-$41.2Mn/m	-$31.4Mn/m	-$26.7M-107.1%	$374.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0n/m	$0-100.0%	$790K

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-K/A	Q3'2510-K/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-K/A
Operating Cash Flow	$33.5M+85.3%	$11.2M-49.8%	-$74.7M-505.4%	$18.1M+29.8%	$22.4M+547.3%	$771Kn/m	$18.4M-30.5%	$13.9M-2.6%
Depreciation & Amortization	$8.6M+2.6%	$8.2M-0.4%	$8.5M+1.8%	$8.3M-2.3%	$8.3M+0.3%	$8.6M+2.8%	$8.3M+2.0%	$8.5M+0.6%
Stock-Based Compensation	N/A	$11.4M	N/A	N/A	N/A	$15.7M+259.0%	N/A	N/A
Capital Expenditures	$3.6M+71.2%	$2.9M-31.2%	$4.1M+5.6%	$2.1M+5.1%	$4.3M+28.6%	$4.8M-3.2%	$3.8M+10.3%	$2.0M-61.1%
Free Cash Flow	$30.0M+87.2%	$8.3M-54.2%	-$78.8M-640.3%	$16.0M+33.9%	$18.1M+12499.3%	-$4.0Mn/m	$14.6M-36.6%	$12.0M+29.9%
Investing Cash Flow	-$3.5Mn/m	-$2.9Mn/m	-$4.1Mn/m	-$2.1Mn/m	-$2.2Mn/m	-$4.8Mn/m	-$3.6Mn/m	-$2.0Mn/m
Financing Cash Flow	-$29.3Mn/m	-$14.5Mn/m	$73.1Mn/m	-$2.2Mn/m	-$13.8Mn/m	-$2.4Mn/m	-$14.9Mn/m	-$4.1Mn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

DCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DCO quarterly financial ratios

Metric	FY2510-K/A	FY2410-K/A	FY2310-K/A	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	26.9%+1.8pp	25.1%+3.5pp	21.6%+1.3pp	20.3%-1.8pp	22.1%+0.2pp	21.9%+0.8pp	21.1%+1.6pp	19.5%+1.0pp	18.5%-0.9pp	19.4%+4.2pp	15.1%-3.8pp	18.9%+2.1pp	16.9%-2.4pp	19.3%+1.0pp	18.2%
Operating Margin	-4.3%-9.7pp	5.4%+1.6pp	3.8%-1.8pp	5.6%-2.0pp	7.6%+0.3pp	7.2%-0.6pp	7.8%+4.0pp	3.8%+1.0pp	2.8%-2.5pp	5.3%+16.6pp	-11.3%-18.3pp	7.0%+1.6pp	5.3%-2.3pp	7.6%+13.5pp	-5.9%
Net Margin	-4.5%-7.3pp	2.8%+0.7pp	2.1%-1.9pp	4.0%-17.0pp	21.0%+16.4pp	4.6%+0.1pp	4.5%+3.1pp	1.4%-2.2pp	3.6%-1.0pp	4.6%+15.8pp	-11.2%-13.9pp	2.7%+1.1pp	1.5%-0.8pp	2.4%+10.5pp	-8.2%
Return on Equity	-5.7%-8.8pp	3.2%+0.7pp	2.5%-3.0pp	5.5%-23.1pp	28.6%+19.7pp	8.9%-2.2pp	11.1%+7.6pp	3.5%-5.0pp	8.5%-3.4pp	11.9%+52.2pp	-40.3%-48.1pp	7.7%+2.9pp	4.9%-3.3pp	8.2%+32.5pp	-24.3%
Return on Assets	-3.1%-5.1pp	1.9%+0.5pp	1.4%-1.4pp	2.8%-11.0pp	13.9%+10.4pp	3.5%-0.6pp	4.1%+2.7pp	1.4%-2.1pp	3.5%-1.4pp	4.9%+18.3pp	-13.4%-16.1pp	2.7%+1.2pp	1.5%-0.8pp	2.3%+8.2pp	-5.9%
Current Ratio	3.49+0.3x	3.24+0.2x	2.99+0.3x	2.64-0.4x	3.03+0.2x	2.87+0.5x	2.36+0.1x	2.25-0.5x	2.75+0.1x	2.62-0.5x	3.15+0.2x	2.96-0.1x	3.080.0x	3.12+0.2x	2.93
Debt-to-Equity	0.45+0.1x	0.34-0.1x	0.41-0.1x	0.46-0.1x	0.59-0.4x	0.95-0.1x	1.03+0.1x	0.900.0x	0.93+0.1x	0.80-0.5x	1.32+0.2x	1.13-0.1x	1.24-0.4x	1.69-0.3x	1.99
Liabilities-to-Equity	0.79+0.1x	0.66-0.1x	0.76-0.2x	0.94-0.1x	1.06-0.5x	1.54-0.2x	1.70+0.2x	1.51+0.1x	1.410.0x	1.43-0.6x	2.00+0.1x	1.91-0.3x	2.26-0.3x	2.59-0.5x	3.09
Asset Turnover	0.700.0x	0.700.0x	0.680.0x	0.700.0x	0.66-0.1x	0.75-0.2x	0.91-0.1x	0.980.0x	0.98-0.1x	1.07-0.1x	1.20+0.2x	0.990.0x	0.970.0x	0.96+0.2x	0.72
FCF Margin	-5.9%-8.4pp	2.5%+1.0pp	1.5%-0.3pp	1.8%+4.5pp	-2.7%-2.7pp	0.0%-4.5pp	4.5%0.0pp	4.5%+3.1pp	1.4%-3.4pp	4.8%+3.6pp	1.2%-3.6pp	4.8%+0.2pp	4.6%+0.3pp	4.3%+7.3pp	-3.0%

Metric	Q3'2610-Q	Q2'2610-Q	Q4'2510-K/A	Q3'2510-K/A	Q2'2510-Q	Q1'2510-Q	Q4'2410-K/A	Q3'2410-K/A
Gross Margin	28.0%+0.5pp	26.9%+0.5pp	27.3%+3.7pp	27.5%+1.3pp	26.4%+0.3pp	26.2%+1.7pp	23.5%+1.8pp	26.2%+3.4pp
Operating Margin	12.6%+47.8pp	7.5%-1.3pp	7.8%+2.3pp	-35.1%-42.8pp	8.8%+7.2pp	2.6%-4.0pp	5.5%+0.9pp	7.7%+3.3pp
Net Margin	9.1%+37.5pp	4.7%-1.6pp	4.3%+1.0pp	-28.4%-33.0pp	6.3%+6.7pp	0.7%-2.6pp	3.3%+0.7pp	4.7%+3.0pp
Return on Equity	2.9%+12.3pp	1.5%-0.3pp	1.4%+0.4pp	-9.4%-10.8pp	1.8%+1.9pp	0.2%-0.8pp	1.0%+0.2pp	1.4%+0.9pp
Return on Assets	1.7%+6.5pp	0.8%-0.3pp	0.8%+0.2pp	-4.9%-5.7pp	1.1%+1.2pp	0.1%-0.4pp	0.6%+0.1pp	0.8%+0.5pp
Current Ratio	3.36+1.3x	3.67+0.4x	3.49+0.3x	2.04-1.2x	3.27+0.2x	3.37+0.4x	3.24+0.2x	3.22+0.3x
Debt-to-Equity	0.39+0.1x	0.45+0.1x	0.45+0.1x	0.330.0x	0.31-0.1x	0.33-0.1x	0.34-0.1x	0.370.0x
Liabilities-to-Equity	0.77-0.2x	0.77+0.2x	0.79+0.1x	0.93+0.2x	0.61-0.1x	0.63-0.1x	0.66-0.1x	0.70-0.1x
Asset Turnover	0.180.0x	0.180.0x	0.180.0x	0.170.0x	0.180.0x	0.170.0x	0.180.0x	0.180.0x
FCF Margin	13.4%+5.9pp	4.0%-5.1pp	-36.3%-43.7pp	7.5%+1.5pp	9.0%+9.0pp	-2.1%+1.4pp	7.4%-4.6pp	5.9%+1.3pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Ducommun Incorporated DCO	FY2025	$824.8M	-$37.4M	-4.5%	$2.4B	46/100
Astronics Corp ATRO	FY2025	$862.1M	$29.4M	3.4%	$2.5B	47/100
Redwire Corporation RDW	FY2025	$335.4M	-$226.6M	-67.5%	$2.1B	42/100
Cadre Holdings, Inc. CDRE	FY2025	$610.3M	$44.1M	7.2%	$1.3B	64/100
V2X, Inc. VVX	FY2025	$4.5B	$77.9M	1.7%	$2.3B	44/100
Eve Holding, Inc. EVEX	FY2025	N/A	-$224.3M	N/A	$571.5M	—

Where Ducommun Incorporated Ranks

Frequently Asked Questions

What is Ducommun Incorporated's annual revenue?

Ducommun Incorporated (DCO) reported $824.8M in total revenue for fiscal year 2025. This represents a 4.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ducommun Incorporated's revenue growing?

Ducommun Incorporated (DCO) revenue grew by 4.9% year-over-year, from $786.4M to $824.8M in fiscal year 2025.

Is Ducommun Incorporated profitable?

No, Ducommun Incorporated (DCO) reported a net loss of $21.2M over the trailing 12 months to July 4, 2026. In fiscal year 2025 it reported a net loss of $37.4M, with a net profit margin of -4.5%.

What is Ducommun Incorporated's EBITDA?

Ducommun Incorporated (DCO) had EBITDA of -$2.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Ducommun Incorporated have?

As of fiscal year 2025, Ducommun Incorporated (DCO) had $45.3M in cash and equivalents against $300.0M in long-term debt.

What is Ducommun Incorporated's gross margin?

Ducommun Incorporated (DCO) had a gross margin of 26.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ducommun Incorporated's operating margin?

Ducommun Incorporated (DCO) had an operating margin of -4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ducommun Incorporated's net profit margin?

Ducommun Incorporated (DCO) had a net profit margin of -4.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ducommun Incorporated's return on equity (ROE)?

Ducommun Incorporated (DCO) has a return on equity of -5.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ducommun Incorporated's free cash flow?

Ducommun Incorporated (DCO) recorded an outflow of $48.6M in free cash flow during fiscal year 2025. This represents a -342.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ducommun Incorporated's operating cash flow?

Ducommun Incorporated (DCO) recorded an outflow of $33.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Ducommun Incorporated's total assets?

Ducommun Incorporated (DCO) had $1.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ducommun Incorporated's capital expenditures?

Ducommun Incorporated (DCO) invested $15.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Ducommun Incorporated have outstanding?

Ducommun Incorporated (DCO) had 15M shares outstanding as of fiscal year 2025.

What is Ducommun Incorporated's current ratio?

Ducommun Incorporated (DCO) had a current ratio of 3.49 as of fiscal year 2025, which is generally considered healthy.

What is Ducommun Incorporated's debt-to-equity ratio?

Ducommun Incorporated (DCO) had a debt-to-equity ratio of 0.45 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Ducommun Incorporated's liabilities-to-equity ratio?

Ducommun Incorporated (DCO) had a liabilities-to-equity ratio of 0.79 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Ducommun Incorporated's return on assets (ROA)?

Ducommun Incorporated (DCO) had a return on assets of -3.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ducommun Incorporated's P/E ratio?

Ducommun Incorporated (DCO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to July 4, 2026). The market capitalization is $2.4B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Ducommun Incorporated's price-to-sales ratio?

Ducommun Incorporated (DCO) trades at 2.7x sales, its market capitalization divided by $865.1M revenue, trailing 12 months to July 4, 2026. The market capitalization is $2.4B as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Ducommun Incorporated's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Ducommun Incorporated (DCO) held $45.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $33.4M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Ducommun Incorporated's Altman Z-Score?

Ducommun Incorporated (DCO) has an Altman Z-Score of 4.24, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ducommun Incorporated's Piotroski F-Score?

Ducommun Incorporated (DCO) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ducommun Incorporated's earnings high quality?

Ducommun Incorporated (DCO) reported a net loss of $37.4M while operations used $33.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Ducommun Incorporated cover its interest payments?

Ducommun Incorporated (DCO) reported an operating loss of $35.7M against $12.7M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Ducommun Incorporated?

Ducommun Incorporated (DCO) scores 46 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.